ASHP guidelines on the pharmacist's role in the development, implementation, and assessment of critical pathways

American Journal of Health-System Pharmacy

Volumn 61, Issue 9, 2004, Pages 939-945

[No Author Info available]

Author keywords

American Society of Health System Pharmacists; Critical pathways; Documentation; Drug use; Drugs; Economics; Guidelines; Pharmacists; Quality assurance; Toxicity

Indexed keywords

CLINICAL PATHWAY; DRUG EFFICACY; DRUG SELECTIVITY; DRUG USE; EVIDENCE BASED MEDICINE; HEALTH CARE QUALITY; HEALTH CARE SYSTEM; LEADERSHIP; MEDICAL DOCUMENTATION; MOTIVATION; PATIENT CARE; PATIENT EDUCATION; PATIENT MONITORING; PHARMACIST; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROCESS MONITORING; PROFESSIONAL PRACTICE; REVIEW; RISK ASSESSMENT; SCIENTIFIC LITERATURE; TEAMWORK; TREATMENT OUTCOME; ARTICLE; HUMAN; MEDICATION ERROR; ORGANIZATION AND MANAGEMENT; PROFESSIONAL STANDARD; TOTAL QUALITY MANAGEMENT; UNITED STATES;

CONTINUITY OF PATIENT CARE; CRITICAL PATHWAYS; GUIDELINES; HUMANS; MEDICATION ERRORS; PHARMACISTS; PROFESSIONAL ROLE; TOTAL QUALITY MANAGEMENT; UNITED STATES;

EID: 3543145430     PISSN: 10792082     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajhp/61.9.939     Document Type: Review

References (42)

1. Darer J, Pronovost P, Bass E. Use and evaluation of critical pathways in hospitals. Eff Clin Pract. 2002; 5:114-9.
2. Lumsdon K, Hagland M. Mapping care. Hosp Health Netw. 1993; 67:34-40.
3. Coffey RJ, Richards JS, Remmert CS et al. An introduction to critical paths. Qual Manag Health Care. 1992; 1:45-54.
4. Jaggers LD. Differentiation of critical pathways from other health care management tools. Am J Health-Syst Pharm. 1996; 53:311-3.
5. Koch KE. Opportunities for pharmaceutical care with critical pathways. Top Hosp Pharm Manag. 1995; 14:1-7.
6. Stevenson LL. Critical pathway experience at Sarasota Memorial Hospital. Am J Health-Syst Pharm. 1995; 52:1071-3.
7. Gousse GC, Rousseau MR. Critical pathways at Hartford Hospital. Am J Health-Syst Pharm. 1995; 52:1060-3.
8. Shane R, Vinson B. Use of critical pathways and indicators in pharmacy practice. Top Hosp Pharm Manag. 1995; 14: 55-67.
9. Gouveia WA, Massaro FJ. Critical pathway experience at New England Medical Center. Am J Health-Syst Pharm. 1995; 52:1068-70.
10. Saltiel E. Critical pathway experience at Cedars-Sinai Medical Center. Am J Health-Syst Pharm. 1995; 52:1063-8.
11. Nelson SP. Critical pathways at University of Iowa Hospitals and Clinics. Am J Health-Syst Pharm. 1995; 52:1058-60.
12. Marrie TJ, Lau CY, Wheeler SL et al. A controlled trial of a critical pathway for treatment of community-acquired pneumonia. CAPITAL Study Investigators. Community-Acquired Pneumonia Intervention Trial Assessing Levofloxacin. JAMA. 2000; 283:749-55.
13. Cannon CP, Hand MH, Bahr R et al. Critical pathways for management of patients with acute coronary syndromes: an assessment by the National Heart Attack Alert Program. Am Heart J. 2002; 143:777-89.
14. Jones S. A clinical pathway for pediatric gastroenteritis. Gastroenterol Nurs. 2003; 26:7-18.
15. Nierman DM. A structure of care for the chronically critically ill. Crit Care Clin. 2002; 18:477-91.
16. Kercsmar CM, Myers TR. Clinical pathways in treatment of asthma. Curr Opin Allergy Clin Immunol. 2002; 2:183-7.
17. Mavroukakis SA, Muehlbauer PM, White RL Jr et al. Clinical pathways for managing patients receiving interleukin 2. Clin J Oncol Nurs. 2001; 5:207-17.
18. Zevola DR, Raffa M, Brown K. Using clinical pathways in patients undergoing cardiac valve surgery. Crit Care Nurse. 2002; 22:31-9,44-50.
19. Rymer MM, Summers D, Soper P. Development of clinical pathways for stroke management: an example from Saint Luke's Hospital, Kansas City. Clin Geriatr Med. 1999; 15:741-64.
20. Bisanz A, DeJesus Y, Saddler DA. Development, implementation, and ongoing monitoring of pathways for the treatment of gastrointestinal cancer at a comprehensive cancer center. Gastroenterol Nurs. 1999; 22:107-14.
21. Sesperez J, Wilson S, Jalaludin B et al. Trauma case management and clinical pathways: prospective evaluation of their effect on selected patient outcomes in five key trauma conditions. J Trauma. 2001; 50:643-9.
22. Mamolen NL, Brenner PS. The impact of a burn wound education program and implementation of a clinical pathway on patient outcomes. J Burn Care Rehabil. 2000; 21:440-5.
23. Crane M, Werber B. Critical pathway approach to diabetic pedal infections in a multidisciplinary setting. J Foot Ankle Surg. 1999; 38:30-3.
24. Baker CM, Miller I, Sitterding M et al. Acute stroke patients comparing outcomes with and without case management. Nurs Case Manag. 1998; 3:196-203.
25. Holtzman J, Bjerke T, Kane R. The effects of clinical pathways for renal transplant on patient outcomes and length of stay. Med Care. 1998; 36:826-34.
26. Petitta A, Kaatz S, Estrada C et al. The transition to medication system performance indicators. Top Hosp Pharm Manag. 1995; 14:20-6.
27. Johnson KB, Blaisdell CJ, Walker A et al. Effectiveness of a clinical pathway for inpatient asthma management. Pediatrics. 2000; 106:1006-12.
28. Philbin EF, Rocco TA, Lindenmuth NW et al. The results of a randomized trial of a quality improvement intervention in the care of patients with heart failure. The MISCHF Study Investigators. Am J Med. 2000; 109:443-9.
29. Murphy M, Noetscher C, Lagoe R. A multihospital effort to reduce inpatient lengths of stay for pneumonia. J Nurs Care Qual. 1999; 13:11-23.
30. Dzwierzynski WW, Spitz K, Hartz A et al. Improvement in resource utilization after development of a clinical pathway for patients with pressure ulcers. Plast Reconstr Surg. 1998; 102:2006-11.
31. Boykin JV Jr, Crossland MC, Cole LM. Wound healing management: enhancing patient outcomes and reducing costs. J Healthc Resour Manag. 1997; 15:22,24-6.
32. Leibman BD, Dillioglugil O, Abbas F et al. Impact of a clinical pathway for radical retropubic prostatectomy. Urology. 1998; 52:94-9.
33. Bailey R, Weingarten S, Lewis M et al. Impact of clinical pathways and practice guidelines on the management of acute exacerbations of bronchial asthma. Chest. 1998; 113:28-33.
34. Uchiyama K, Takifuji K, Tani M et al. Effectiveness of the clinical pathway to decrease length of stay and cost for laparoscopic surgery. Surg Endosc. 2002; 16: 1594-7.
35. Wilson SD, Dahl BB, Wells RD. An evidence-based clinical pathway for bronchiolitis safely reduces antibiotic overuse. Am J Med Qual. 2002; 17:195-9.
36. Smith DM, Gow P. Towards excellence in quality patient care: a clinical pathway for myocardial infarction. J Qual Clin Pract. 1999; 19:103-5.
37. Kirk JK, Michael KA, Markowsky SJ et al. Critical pathways: the time is here for pharmacist involvement. Pharmacotherapy. 1996; 16:723-33.
38. Institute for Safe Medication Practices. Medication safety self-assessment. www.ismp.org/pages/mssacaprdf.html (accessed 2003 May 16).
39. American Society of Hospital Pharmacists. ASHP statement on pharmaceutical care. Am J Hosp Pharm. 1993; 50:1720-3.
40. American Society of Hospital Pharmacists. ASHP statement on principles for including medications and pharmaceutical care in health care systems. Am J Hosp Pharm. 1993; 50:756-7.
41. American Society of Health-System Pharmacists. ASHP guidelines on a standardized method for pharmaceutical care. Am J Health-Syst Pharm. 1996; 53:1713-6.
42. American Society of Health-System Pharmacists. ASHP guidelines on medication-use evaluation. Am J Health-Syst Pharm. 1996; 53:1953-5.